Home Compare INCY vs RMD
Stock Comparison · Close comparison

Incyte vs ResMed: Which Stock Looks Stronger in 2026?

The structural profiles are close, with ResMed carrying a narrow edge on profitability. The remaining gap is narrow enough that the comparison remains open to different readings. In the market, yte carries the stronger setup — intact trend against ResMed's broken trend. That leaves a split case: the structural lead stays with ResMed, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The comparison stays tight enough that no single part of the profile fully breaks it open.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #5
within Incyte Corporation's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The match is driven mainly by capital structure and revenue stability.

Similarity drivers
capital structurerevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
INCY
Incyte Corporation
84
Peer-Score
Signal qualityHigh
vs
RMD
ResMed Inc.
87
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: INCY vs RMD Profitability 91 100 Stability 73 72 Valuation 86 84 Growth 83 86 INCY RMD
Gap Ranking
#1 Profitability +9
#2 Growth +3
#3 Valuation +2
#4 Stability +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for INCY and RMD Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer INCYRMD Relative valuation Structural strength

Incyte Corporation and ResMed Inc. look relatively close on structure, but the price setup still leans toward Incyte Corporation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both sit in the stronger range on profitability, with Incyte Corporation holding the higher position.
Profitability — Dominant Gap
INCY
91
RMD
100
Gap+9in favour of RMD

The profitability lead is mainly driven by a 9.6-point operating margin advantage.

What keeps the gap from being one-sided

On the market side, yte carries the stronger trend while ResMed's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is visible, but the profile still looks more volatile than a fully settled winner.

Explore full peer positioning in AssetNext

Break down the INCY vs RMD comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other close comparisons

Explore how INCY and RMD each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.